About this Journal Submit a Manuscript Table of Contents
Depression Research and Treatment
Volume 2012 (2012), Article ID 485249, 6 pages
http://dx.doi.org/10.1155/2012/485249
Research Article

Altered Neurochemical Ingredient of Hippocampus in Patients with Bipolar Depression

Department of Psychiatry, School of Medicine, Firat University, 23119 Elazig, Turkey

Received 22 August 2011; Accepted 13 November 2011

Academic Editor: Po-See Chen

Copyright © 2012 Murad Atmaca and Hanefi Yildirim. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. C. Drevets, J. L. Price, J. R. Simpson et al., “Subgenual prefrontal cortex abnormalities in mood disorders,” Nature, vol. 386, no. 6627, pp. 824–827, 1997. View at Scopus
  2. Y. Hirayasu, M. E. Shenton, D. F. Salisbury et al., “Subgenual cingulate cortex volume in first-episode psychosis,” American Journal of Psychiatry, vol. 156, no. 7, pp. 1091–1093, 1999. View at Scopus
  3. S. M. Strakowski, M. P. DelBello, K. W. Sax et al., “Brain magnetic resonance imaging of structural abnormalities in bipolar disorder,” Archives of General Psychiatry, vol. 56, no. 3, pp. 254–260, 1999. View at Scopus
  4. L. L. Altshuler, G. Bartzokis, T. Grieder et al., “An MRI study of temporal lobe structures in men with bipolar disorder or schizophrenia,” Biological Psychiatry, vol. 48, no. 2, pp. 147–162, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Brambilla, K. Harenski, M. Nicoletti et al., “MRI investigation of temporal lobe structures in bipolar patients,” Journal of Psychiatric Research, vol. 37, no. 4, pp. 287–295, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. A. L. Stoll, P. F. Renshaw, D. A. Yurgelun-Todd, and B. M. Cohen, “Neuroimaging in bipolar disorder: what have we learned?” Biological Psychiatry, vol. 48, no. 6, pp. 505–517, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Lyoo, H. K. Lee, J. H. Jung, G. G. Noam, and P. F. Renshaw, “White matter hyperintensities on magnetic resonance imaging of the brain in children with psychiatric disorders,” Comprehensive Psychiatry, vol. 43, no. 5, pp. 361–368, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Atmaca, H. Ozdemir, S. Cetinkaya et al., “Cingulate gyrus volumetry in drug free bipolar patients and patients treated with valproate or valproate and quetiapine,” Journal of Psychiatric Research, vol. 41, no. 10, pp. 821–827, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. M. Atmaca, H. Ozdemir, and H. Yildirim, “Corpus callosum areas in first-episode patients with bipolar disorder,” Psychological Medicine, vol. 37, no. 5, pp. 699–704, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. H. P. Blumberg, E. Stern, S. Ricketts et al., “Rostral and orbital prefrontal cortex dysfunction in the manic state of bipolar disorder,” American Journal of Psychiatry, vol. 156, no. 12, pp. 1986–1988, 1999. View at Scopus
  11. M. Atmaca, H. Yildirim, H. Ozdemir, A. K. Poyraz, E. Tezcan, and E. Ogur, “Hippocampal 1H MRS in first-episode bipolar I patients,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 30, no. 7, pp. 1235–1239, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. M. Atmaca, H. Yildirim, H. Ozdemir, E. Ogur, and E. Tezcan, “Hippocampal 1H MRS in patients with bipolar disorder taking valproate versus valproate plus quetiapine,” Psychological Medicine, vol. 37, no. 1, pp. 121–129, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. J. Urenjak, S. R. Williams, D. G. Gadian, and M. Noble, “Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types,” Journal of Neuroscience, vol. 13, no. 3, pp. 981–989, 1993. View at Scopus
  14. J. R. Moffett and M. A. A. Namboodiri, “Differential distribution of n-acetylaspartylglutamate and n-acetylaspartate immunoreactivities in rat forebrain,” Journal of Neurocytology, vol. 24, no. 6, pp. 409–433, 1995. View at Publisher · View at Google Scholar · View at Scopus
  15. B. G. Jenkins, P. Klivenyi, E. Kustermann et al., “Nonlinear decrease over time in N-acetyl aspartate levels in the absence of neuronal loss and increases in glutamine and glucose in transgenic Huntington's disease mice,” Journal of Neurochemistry, vol. 74, no. 5, pp. 2108–2119, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. O. A. C. Petroff, L. D. Errante, D. L. Rothman, J. H. Kim, and D. D. Spencer, “Neuronal and glial metabolite content of the epileptogenic human hippocampus,” Annals of Neurology, vol. 52, no. 5, pp. 635–642, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. L. R. Baxter, J. M. Schwartz, M. E. Phelps et al., “Reduction of prefrontal cortex glucose metabolism common to three types of depression,” Archives of General Psychiatry, vol. 46, no. 3, pp. 243–250, 1989. View at Scopus
  18. W. C. Drevets, “Prefrontal cortical-amygdalar metabolism in major depression,” Annals of the New York Academy of Sciences, vol. 877, pp. 614–637, 1999. View at Publisher · View at Google Scholar · View at Scopus
  19. M. E. Winsberg, N. Sachs, D. L. Tate, E. Adalsteinsson, D. Spielman, and T. A. Ketter, “Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder,” Biological Psychiatry, vol. 47, no. 6, pp. 475–481, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Hamakawa, T. Kato, T. Shioiri, T. Inubushi, and N. Kato, “Quantitative proton magnetic resonance spectroscopy of the bilateral frontal lobes in patients with bipolar disorder,” Psychological Medicine, vol. 29, no. 3, pp. 639–644, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Bertolino, M. Frye, J. H. Callicott et al., “Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging,” Biological Psychiatry, vol. 53, no. 10, pp. 906–913, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Chang, N. Adleman, K. Dienes, N. Barnea-Goraly, A. Reiss, and T. Ketter, “Decreased N-Acetylaspartate in children with familial bipolar disorder,” Biological Psychiatry, vol. 53, no. 11, pp. 1059–1065, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. J. C. Soares and J. J. Mann, “The functional neuroanatomy of mood disorders,” Journal of Psychiatric Research, vol. 31, no. 4, pp. 393–432, 1997. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Rajkowska, A. Halaris, and L. D. Selemon, “Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder,” Biological Psychiatry, vol. 49, no. 9, pp. 741–752, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. G. J. Moore, J. M. Bebchuk, K. Hasanat et al., “Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects?” Biological Psychiatry, vol. 48, no. 1, pp. 1–8, 2000. View at Publisher · View at Google Scholar · View at Scopus
  26. R. F. Deicken, M. P. Pegues, S. Anzalone, R. Feiwell, and B. Soher, “Lower concentration of hippocampal N-acetylaspartate in familial bipolar I disorder,” American Journal of Psychiatry, vol. 160, no. 5, pp. 873–882, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Corapcioglu, O. Aydemir, M. Yıldız, et al., DSM-IV Eksen I Bozuklukları (SCID-I) İçin Yapılandırılmış Klinik Görüşme, Klinik Versiyon. Hekimler Yayın Birliği, Ankara, Turkey, 1999.
  28. M. Hamilton, “A rating scale for depression,” Journal of Neurology, Neurosurgery, and Psychiatry, vol. 23, pp. 56–62, 1960. View at Scopus
  29. R. C. Young, J. T. Biggs, V. E. Ziegler, and D. A. Meyer, “A rating scale for mania: reliability, validity and sensitivity,” British Journal of Psychiatry, vol. 133, no. 11, pp. 429–435, 1978. View at Scopus
  30. J. Talairach and P. Tournoux, Coplanar Stereotaxic Atlas of the Human Brain, Thieme Medical Publishers, New York, NY, USA, 1998.
  31. M. E. Winsberg, N. Sachs, D. L. Tate, E. Adalsteinsson, D. Spielman, and T. A. Ketter, “Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder,” Biological Psychiatry, vol. 47, no. 6, pp. 475–481, 2000. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Atmaca, H. Yildirim, H. Ozdemir, M. Koc, S. Ozler, and E. Tezcan, “Neurochemistry of the hippocampus in patients with obsessive-compulsive disorder: regular article,” Psychiatry and Clinical Neurosciences, vol. 63, no. 4, pp. 486–490, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. I. M. Burtscher and S. Holtas, “Proton MR spectroscopy in clinical routine,” Journal of Magnetic Resonance Imaging, vol. 13, no. 4, pp. 560–567, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. G. S. Malhi, M. Valenzuela, W. Wen, and P. Sachdev, “Magnetic resonance spectroscopy and its applications in psychiatry,” Australian and New Zealand Journal of Psychiatry, vol. 36, no. 1, pp. 31–43, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. D. P. Soares and M. Law, “Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications,” Clinical Radiology, vol. 64, no. 1, pp. 12–21, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. G. J. Moore and M. P. Galloway, “Magnetic resonance spectroscopy: neurochemistry and treatment effects in affective disorders,” Psychopharmacology Bulletin, vol. 36, no. 2, pp. 5–23, 2002. View at Scopus
  37. A. Milne, G. M. MacQueen, K. Yucel, N. Soreni, and G. B. C. Hall, “Hippocampal metabolic abnormalities at first onset and with recurrent episodes of a major depressive disorder: a proton magnetic resonance spectroscopy study,” NeuroImage, vol. 47, no. 1, pp. 36–41, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. H. Hortnagl, M. L. Berger, L. Havelec, and O. Hornykiewicz, “Role of glucocorticoids in the cholinergic degeneration in rat hippocampus induced by ethylcholine aziridinium (AF64A),” Journal of Neuroscience, vol. 13, no. 7, pp. 2939–2945, 1993. View at Scopus